An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...
In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...
Please provide your email address to receive an email when new articles are posted on . The researchers identified 390 reactions requiring epinephrine during 1,637 cases of home administration of oral ...
Based on real-world data, 92.3% of patients achieved rapid symptom resolution after receiving a single dose of epinephrine nasal spray for systemic reactions. Intranasal epinephrine was found to be ...
SAN DIEGO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients ...
Please provide your email address to receive an email when new articles are posted on . Subjects had two doses each of Belhaven Biopharma’s BBP01 and intramuscular epinephrine. Subjects had faster and ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results